Research Output per year
Fingerprint Dive into the research topics where Catherine S Perry is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 4 Similar Profiles
Non-Hodgkin's Lymphoma
Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse
Medicine & Life Sciences
Lymphoma
Medicine & Life Sciences
Peripheral T-Cell Lymphoma
Medicine & Life Sciences
B-Cell Lymphoma
Medicine & Life Sciences
Phenotype
Medicine & Life Sciences
B-Lymphocytes
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1984 2018
18
Citations
(Scopus)
Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus 131I-Tositumomab: Long-Term follow-up of phase III randomized study SWOG-S0016
Shadman, M., Li, H., Rimsza, L. M., Leonard, J. P., Kaminski, M. S., Braziel, R. M., Perry, C. S., Gopal, A. K., Maloney, D. G., Cheson, B. D., Dakhil, S., LeBlanc, M., Smith, S. M., Fisher, R. I., Friedberg, J. W. & Press, O. W., Mar 1 2018, In : Journal of Clinical Oncology. 36, 7, p. 697-703 7 p.Research output: Contribution to journal › Article
Follicular Lymphoma
Therapeutics
Second Primary Neoplasms
Myelodysplastic Syndromes
Acute Myeloid Leukemia
3
Citations
(Scopus)
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort
Rimsza, L. M., Li, H., Braziel, R. M., Perry, C. S., Persky, D. O., Dunlap, J., Leblanc, M., Bartlett, N., Leonard, J. P., Smith, S. M., Press, O. W. & Friedberg, J. W., Mar 23 2018, In : Haematologica. 103, 4, p. e151-e153Research output: Contribution to journal › Letter
Follicular Lymphoma
3
Citations
(Scopus)
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
Kelly, K. R., Friedberg, J. W., Park, S. I., McDonagh, K., Hayslip, J., Persky, D., Ruan, J., Puvvada, S. D., Rosen, P., Iyer, S. P., Stefanovic, A., Bernstein, S. H., Weitman, S., Karnad, A., Monohan, G., VanderWalde, A., Mena, R., Schmelz, M., Perry, C. S., Groshen, S. & 5 others, , Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6150-6159 10 p.Research output: Contribution to journal › Article
Aurora Kinase A
Vincristine
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma, Large B-Cell, Diffuse
5
Citations
(Scopus)
Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: A novel therapeutic strategy
Islam, S., Vick, E., Huber, B., Morales, C., Perry, C. S., Cooke, L., Weterings, E. . & Mahadevan, D., Jan 1 2017, In : Oncotarget. 8, 59, p. 100326-100338 13 p.Research output: Contribution to journal › Article
Aurora Kinases
Peripheral T-Cell Lymphoma
Phosphatidylinositol 3-Kinases
Non-Hodgkin's Lymphoma
Vincristine
10
Citations
(Scopus)
Disruption of aneuploidy and senescence induced by aurora inhibition promotes intrinsic apoptosis in double hit or double expressor diffuse large B-cell lymphomas
Islam, S., Qi, W., Morales, C., Cooke, L., Perry, C. S., Weterings, E. . & Mahadevan, D., Oct 1 2017, In : Molecular Cancer Therapeutics. 16, 10, p. 2083-2093 11 p.Research output: Contribution to journal › Article
Lymphoma, Large B-Cell, Diffuse
Aneuploidy
Apoptosis
Aurora Kinases
Cell Death